Esperion says Renata will not market generic NEXLETOL/NEXLIZET until 2040
Valid market news retained in the public archive without immediate LiveCast distribution.
Story updates
12:09:53 PM UTC
SquawkNews
* Esperion: Renata Agreed Not to Market Generic Version of Either NEXLETOL or NEXLIZET in U.S. Prior to April 19, 2040, Unless Certain Limited Circumstances Occur